Enliven Therapeutics, Inc. (Enliven or the Company) , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the Company ...
Genetic testing presents major growth opportunities in predictive diagnostics, pharmacogenomic testing, and direct-to-consumer markets. With increasing test volumes and lower prices, the industry is ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
Genetix Biotherapeutics Inc. today announced that an analysis of recent patient experience data from the commercial implementation of LYFGENIAtm and ZYNTEGLOtm in the U.S. has been selected for oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback